MedTrace Logo

Using AI to Select Women for Supplemental MRI in Breast Cancer Screening

NCT04832594 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2500

Last updated 2023-10-05

No results posted yet for this study

Summary

This is a prospective clinical trial aiming to determine the ability of an AI pipeline to identify women who would benefit from supplemental MRI in terms of decreasing the number of cancers having a significantly delayed detection

Conditions

Interventions

OTHER

AI selection for supplemental breast MRI

An AI tool will generate scores used to determine eligibility. Women randomized to MRI will be examined in an MRI scanner.

Sponsors & Collaborators

  • KTH Royal Institute of Technology

    collaborator OTHER

  • Region Stockholm

    collaborator OTHER_GOV

  • Bröstcancerförbundet, Sweden

    collaborator UNKNOWN

  • Karolinska University Hospital

    lead OTHER

Principal Investigators

  • Fredrik Strand, MDPhD · Karolinska University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-04-01
Completion
2025-07-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04832594 on ClinicalTrials.gov